NeurOmics was a research project funded by the European Commission for five years (10/2012-09/2017).

The project studied 10 rare neurodegenerative and neuromuscular diseases with the aims to: a) find novel disease-causing genes, b) improve diagnostics, and c) develop novel therapies for these disorders.

The project brought together the important stakeholders in the field, from researchers, clinicians, bioinformaticians, patients, and ethics experts to SMEs.